Pfizer Inc

FDA Advisory Committee Finds Data Support The Safety And Effectiveness Of Prevnar 13™ Vaccine For The Prevention Of Invasive Pneumococcal Diseas

Medical News Today (Free subscription) | 20/11/2009

Pfizer Inc (NYSE:PFE) announced today that the U.S.

FDA Advisory Committee Finds Data Support the Safety and Effectiveness of Prevnar 13™ Vaccine for the Prevention of Invasive Pneumococcal Disease in Infants and Young Children

Business Wire (Free subscription) | 19/11/2009

NEW YORK--(BUSINESS WIRE)--Pfizer Inc (NYSE:PFE) announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee voted 10 to 1 that the data presented support the safety and effectiveness of its 13-valent pneumococcal conjugate candidate vaccine, Prevnar 13™ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]),...

Pfizer Submits New Pediatric Data For Lipitor(R) (Atorvastatin) To The European Medicines Agency (EMEA)

Medical News Today (Free subscription) | 19/11/2009

Pfizer Inc (NYSE:PFE) announced it has submitted pediatric data for Lipitor® (atorvastatin) to the European Medicines Agency (EMEA). Pfizer has also developed a new chewable form of Lipitor, including a pediatric-appropriate 5 mg dose, which is part of this submission.

U.S. FDA wants panel to probe Pfizer vaccine efficacy

Sify (Free subscription) | 18/11/2009

Pfizer Inc's next- generation Prevnar vaccine missed some of the main goals in a study testing its ability to protect against bacteria that cause ear infections, pneumonia and other diseases, U.S.

Pfizer and DNDi Advancing International Research Efforts In The Fight Against Neglected Tropical Diseases

Business Wire (Free subscription) | 18/11/2009

NEW YORK & GENEVA--(BUSINESS WIRE)--Pfizer Inc and Drugs for Neglected Diseases initiative (DNDi) have signed an agreement that is designed to facilitate advancements in the battle against human African trypanosomiasis (HAT), visceral leishmaniasis (VL) and Chagas disease, which afflict vulnerable populations in the developing world. Under the agreement, DNDi will have access to the Pfizer library...

Pfizer Submits New Pediatric Data For Lipitor® (Atorvastatin) To The European Medicines Agency (EMEA)

Business Wire (Free subscription) | 18/11/2009

NEW YORK--(BUSINESS WIRE)--Pfizer Inc (NYSE:PFE) announced it has submitted pediatric data for Lipitor® (atorvastatin) to the European Medicines Agency (EMEA). Pfizer has also developed a new chewable form of Lipitor, including a pediatric-appropriate 5 mg dose, which is part of this submission. Approximately one in 500 people suffer from an inherited disorder, called Familial Hypercholesterolemia...

LiquidStockReport.com on Lucrative Market Opportunities - GELV

Radon Mitigation Pittsburgh (Free subscription) | 14/11/2009

( EMAILWIRE.COM , November 13, 2009 ) Del Mar, CA Green Energy Live has astutely chosen to initially target its focus on manure to energy conversion systems for farmers where it can have the largest and quickest impact. Technology that enables livestock operators to generate electricity while disposing of animal waste will be hugely valuable to the agriculture industry. GELV's solutions will allow...

• LiquidStockReport.com on GELV - Enabling Farmers to Attain Energy Independence - EmailWire.Com
• LiquidStockReport.com on Lucrative Market Opportunities - GELV - EmailWire.Com
• See the 4 articles on the same subject

Pfizer Caught in Yet More Science Fraud: Company Altered Study Findings Over Neurontin Drug

Connecting the Dots in the New World Order (Free subscription) | 13/11/2009

A study of internal company documents suggests Pfizer Inc altered or omitted unfavorable study findings to expand its epilepsy drug Neurontin's market, U.S. researchers said on Wednesday, offering a look at how drugmakers influence scientific research.' Read more...

Governor-Elect Christie Announces Chairs of Transition Task Force on Budget and Taxes

MoreMonmouthMusings (Free subscription) | 12/11/2009

Trenton, NJ – Governor-Elect Chris Christie today named two budget and fiscal experts to chair a special Transition Task Force on Budget and Taxes and asked them to get to work immediately on developing recommendations to help address New Jersey’s fiscal challenges. The Governor-Elect named Richard H. Bagger of Westfield, an executive at Pfizer Inc and a former Chairman of the Assembly...

Report Shows Pfizer Fudged Drug Studies

CommonDreams.org Headlines (Free subscription) | 12/11/2009

by Julie Steenhuysen CHICAGO - A study of internal company documents suggests Pfizer Inc altered or omitted unfavorable study findings to expand its epilepsy drug Neurontin's market, U.S. researchers said on Wednesday, offering a look at how drugmakers influence scientific research. Clinical trials are supposed to answer a specific, predetermined scientific question, but a comparison of Pfizer documents...

• Report shows Pfizer's hand in Neurontin studies - Reuters UK

Report Shows Pfizer's Hand In Neurontin Studies

Health - The Post Chronicle (Free subscription) | 12/11/2009

A study of internal company documents suggests Pfizer Inc altered or omitted unfavorable study findings to expand its epilepsy drug Neurontin's market....

Pfizer Moving Fast with Wyeth Integration – Software Analysis Can Help Make this Happen

The Medical Quack (Free subscription) | 12/11/2009

Going back in time I can remember the acquisition of Warner Lambert, which since has been purchased by Johnson and Johnson as I used to do business with Pfizer and yet it seemed like it took forever. Not only in pharma, but I think today all mergers and acquisitions are moving at rocket speeds, first of all simply due to the economy. Second of all, it is possible today with business intelligence software...

The Kelo Case Redux Once More: Pfizer Pulls Out and the "Carefully Formulated" Development Plan Collapses

Health Care Renewal (Free subscription) | 10/11/2009

Four years ago we posted ( here , here and here ) about the controversial US Supreme Court decision in the Kelo case. Most discussion of the case at the time focused on individual property rights vs the power of the government to promote economic development, but the case had an important health care angle. Briefly, the case centered on the taking of private property, including a house owned by Susette...

Pfizer will close R&D sites and cut jobs

Reuters UK (Free subscription) | 10/11/2009

NEW YORK (Reuters) - Pfizer Inc , the world's biggest drugmaker, will close six research and development sites and trim jobs in the Unites States and the United Kingdom, following the acquisition of Wyeth.

StockSource.us Reports on Self Contained Solutions from MNDP

Radon Mitigation Pittsburgh (Free subscription) | 10/11/2009

( EMAILWIRE.COM , November 09, 2009 ) Del Mar, CA - AirStar International, a subsidiary of Mundus, Group, Inc., has been an innovator and world leader in the design, engineering, development, production and sales in Unmanned Air Vehicles and Remote Controlled Vertical Take Off and Landing technology for the past 20 years. They now announce the formation of their new division, AirStar Foto Worx which...

• StockSource.us Reports on Self Contained Solutions from MNDP - EmailWire.Com